PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 114 filers reported holding PROVENTION BIO INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $85,000 | -38.8% | 3,549 | -72.9% | 0.00% | – |
| Q4 2022 | $139,000 | +297.1% | 13,089 | +68.5% | 0.00% | – |
| Q3 2022 | $35,000 | +218.2% | 7,769 | +166.5% | 0.00% | – |
| Q2 2022 | $11,000 | -78.4% | 2,915 | -58.7% | 0.00% | – |
| Q1 2022 | $51,000 | -23.9% | 7,064 | -40.9% | 0.00% | – |
| Q4 2021 | $67,000 | +55.8% | 11,959 | +77.3% | 0.00% | – |
| Q3 2021 | $43,000 | -21.8% | 6,744 | +3.2% | 0.00% | – |
| Q2 2021 | $55,000 | +14.6% | 6,534 | +44.9% | 0.00% | – |
| Q1 2021 | $48,000 | +220.0% | 4,508 | +407.1% | 0.00% | – |
| Q4 2020 | $15,000 | +36.4% | 889 | 0.0% | 0.00% | – |
| Q3 2020 | $11,000 | -21.4% | 889 | -7.4% | 0.00% | – |
| Q2 2020 | $14,000 | +180.0% | 960 | +92.0% | 0.00% | – |
| Q1 2020 | $5,000 | -64.3% | 500 | -47.4% | 0.00% | – |
| Q4 2019 | $14,000 | +40.0% | 950 | -39.4% | 0.00% | – |
| Q3 2019 | $10,000 | – | 1,567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 14,879,023 | $157,271,273 | 9.67% |
| MPM BioImpact LLC | 898,483 | $9,496,965 | 2.46% |
| VR Adviser, LLC | 1,118,653 | $11,824,162 | 1.99% |
| Ghost Tree Capital, LLC | 400,000 | $4,228,000 | 1.80% |
| EAM Investors, LLC | 276,250 | $2,919,963 | 0.60% |
| EAM Global Investors LLC | 209,856 | $2,218,178 | 0.57% |
| 683 Capital Management, LLC | 550,000 | $5,813,500 | 0.49% |
| Palo Alto Investors LP | 390,800 | $4,130,756 | 0.35% |
| CABOT WEALTH MANAGEMENT INC | 184,271 | $1,948 | 0.33% |
| ADVISORY RESEARCH INC | 288,707 | $3,051,633 | 0.29% |